2021 annual financial data
Viridian Therapeutics 2021 Operating margin
Direct answer
Operating margin was -2,690.79%.
Operating income was -79,728,000 USD and net income was -79,413,000 USD.
Operating cash flow was -54,581,000 USD.
Get free Viridian Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 2,963,000 USD
- Operating income
- -79,728,000 USD
- Net income
- -79,413,000 USD
- Operating cash flow
- -54,581,000 USD